Science Behind Targeted Drug for Pediatric Brain Cancer Has Dana-Farber Roots | Dana-Farber Cancer Institute
Scientific detective work helped transform a previously shelved drug into a medicine now approved for relapsed or progressive pediatric low-grade glioma.